Literature DB >> 14629648

Elevated urinary 8-hydroxydeoxyguanosine, a biomarker of oxidative stress, and lack of association with antioxidant vitamins in chronic obstructive pulmonary disease.

Tadashi Igishi1, Yutaka Hitsuda, Kazuhiro Kato, Takanori Sako, Naoto Burioka, Kazuhito Yasuda, Hiroyuki Sano, Yasushi Shigeoka, Hirofumi Nakanishi, Eiji Shimizu.   

Abstract

OBJECTIVE: The purpose of this study was to investigate whether patients with COPD are under oxidative stress and to elucidate the relationship between the level of oxidative stress and antioxidant vitamins.
METHODOLOGY: Nineteen male patients with COPD and 13 age- matched male control subjects were studied. Urinary 8-hydroxydeoxyguanosine (8-OHdG) concentrations were determined using an enzyme-linked immunosorbent assay kit and corrected for creatinine concentrations. Serum levels of vitamin C, alpha-tocopherol, and beta-carotene were determined by high performance liquid chromatography.
RESULTS: The median (interquartile range) 8-OHdG excretion was 8.1 ng/mg (5.3-10.9 ng/mg) in control subjects and 12.2 ng/mg (9.8-15.5 ng/mg) in COPD patients (P < 0.01). Urinary 8-OHdG levels were significantly elevated in ex-smokers in the COPD group compared with ex-smokers in the control group. Urinary 8-OHdG level was negatively correlated with FVC (r = -0.42, P = 0.016), FEV1 (r = -0.49, P = 0.0048), and oxygen tension in arterial blood (r = -0.41, P = 0.0005). No significant differences in antioxidant levels were demonstrated between the two groups. There were no significant correlations between urinary 8-OHdG excretion and the serum concentrations of antioxidant vitamins.
CONCLUSION: The burden of oxidative stress was observed to increase in COPD patients as judged by urinary 8-OHdG. A depletion of antioxidant vitamins in serum was not essential for this phenomenon. Elevated urinary 8-OHdG level may not be attributable to smoking status or to antioxidant vitamins in COPD.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14629648     DOI: 10.1046/j.1440-1843.2003.00490.x

Source DB:  PubMed          Journal:  Respirology        ISSN: 1323-7799            Impact factor:   6.424


  23 in total

Review 1.  The pharmokinetic limitations of antioxidant treatment for COPD.

Authors:  Robert Foronjy; Alison Wallace; Jeanine D'Armiento
Journal:  Pulm Pharmacol Ther       Date:  2007-10-23       Impact factor: 3.410

2.  Effects of nutritional supplementation with antioxidant vitamins and minerals and fish oil on antioxidant status and psychosocial stress in smokers: an open trial.

Authors:  H Nitta; M Kinoyama; A Watanabe; K Shirao; H Kihara; M Arai
Journal:  Clin Exp Med       Date:  2008-01-11       Impact factor: 3.984

3.  The Effect of Cigarette Smoke-derived Oxidants on the Inflammatory Response of the Lung.

Authors:  Robert Foronjy; Jeanine D'Armiento
Journal:  Clin Appl Immunol Rev       Date:  2006-01-01

4.  SIRT1 protects against cigarette smoke-induced lung oxidative stress via a FOXO3-dependent mechanism.

Authors:  Hongwei Yao; Isaac K Sundar; Tanveer Ahmad; Chad Lerner; Janice Gerloff; Alan E Friedman; Richard P Phipps; Patricia J Sime; Michael W McBurney; Leonard Guarente; Irfan Rahman
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-03-14       Impact factor: 5.464

5.  Short-term traffic related exposures and biomarkers of nitro-PAH exposure and oxidative DNA damage.

Authors:  Andreas M Neophytou; Jaime E Hart; Yan Chang; Junfeng Jim Zhang; Thomas J Smith; Eric Garshick; Francine Laden
Journal:  Toxics       Date:  2014-09

Review 6.  Novel drug delivery systems targeting oxidative stress in chronic obstructive pulmonary disease: a review.

Authors:  You Xu; Hongmei Liu; Lei Song
Journal:  J Nanobiotechnology       Date:  2020-10-19       Impact factor: 10.435

Review 7.  Current concepts on oxidative/carbonyl stress, inflammation and epigenetics in pathogenesis of chronic obstructive pulmonary disease.

Authors:  Hongwei Yao; Irfan Rahman
Journal:  Toxicol Appl Pharmacol       Date:  2011-02-04       Impact factor: 4.219

8.  Superoxide dismutase expression attenuates cigarette smoke- or elastase-generated emphysema in mice.

Authors:  Robert F Foronjy; Oleg Mirochnitchenko; Olga Propokenko; Vincent Lemaitre; Yuxia Jia; Masayori Inouye; Yasunori Okada; Jeanine M D'Armiento
Journal:  Am J Respir Crit Care Med       Date:  2005-12-30       Impact factor: 21.405

Review 9.  8-Oxoguanine DNA glycosylase-1-driven DNA base excision repair: role in asthma pathogenesis.

Authors:  Xueqing Ba; Leopoldo Aguilera-Aguirre; Sanjiv Sur; Istvan Boldogh
Journal:  Curr Opin Allergy Clin Immunol       Date:  2015-02

10.  8-Oxoguanine DNA glycosylase1-driven DNA repair-A paradoxical role in lung aging.

Authors:  Peter German; David Saenz; Peter Szaniszlo; Leopoldo Aguilera-Aguirre; Lang Pan; Muralidhar L Hegde; Attila Bacsi; Gyorgy Hajas; Zsolt Radak; Xueqing Ba; Sankar Mitra; John Papaconstantinou; Istvan Boldogh
Journal:  Mech Ageing Dev       Date:  2016-06-21       Impact factor: 5.432

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.